In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

University of California, Riverside scientists have designed novel agents that bind to and degrade Pin1, a protein linked to ...

Biopharma developer Kesmalea appoints Robert Johnson as CEO to lead development of pipeline focused on oral, CNS penetrant ...

KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...

KinCon biolabs now uses its technology to predict and this in living cells, whether drug candidates effectively bind to ...

Selective protein degradation by the ubiquitin–proteasome ... of disease comprehensively within one issue; instead, our approach has been to highlight a few areas of cell biology in which ...

Key Business Updates BRUKINSA ® (zanubrutinib) is an orally available, small molecule inhibitor of BTK designed to deliver ...

“A shift to more sustainable consumption patterns is needed,” the report summarizes, noting that this is crucial on health ...